Altamira Therapeutics Ltd. Payables For Purchase Of Noncurrent Assets
Altamira Therapeutics Ltd. (CYTOF) had Payables For Purchase Of Noncurrent Assets of CHE 0 as of 2021-12-31, per its 20-F filed 2022-04-12.
Discontinued › Notes
ifrs-full:PayablesForPurchaseOfNoncurrentAssets · last filed 2022-04-12
- 2020-12-31: Payables For Purchase Of Noncurrent Assets 0.00 CHF.
- 2019-12-31: Payables For Purchase Of Noncurrent Assets 2.32K CHF.
- 2018-12-31: Payables For Purchase Of Noncurrent Assets 15.03K CHF.
CHF
| Period end | Payables For Purchase Of Noncurrent Assets |
|---|---|
| 2020-12-31 | 0.00 CHF 20-F · filed 2022-04-12 |
| 2019-12-31 | 2.32K CHF 20-F · filed 2020-04-16 |
| 2018-12-31 | 15.03K CHF 20-F · filed 2021-03-31 |
USD
| Period end | Payables For Purchase Of Noncurrent Assets |
|---|---|
| 2020-12-31 | $0.00 20-F · filed 2021-03-31 |
| 2019-12-31 | $2.32K 20-F · filed 2021-03-31 |
CHE
| Period end | Payables For Purchase Of Noncurrent Assets |
|---|---|
| 2021-12-31 | 0.00 CHE 20-F · filed 2022-04-12 |
| 2019-12-31 | 2.32K CHE 20-F · filed 2022-04-12 |